Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres
Although this is a retrospective study, we demonstrated convincing efficacy of bevacizumab in the treatment of patients with HHT, with a good risk-benefit balance.
Authors
- Urban W. Geisthoff (ORCID: https://orcid.org/0000-0002-3555-5271)
- Sophie Dupuis‐Girod (ORCID: https://orcid.org/0000-0002-8834-5526)
- Jean‐Christophe Saurin (ORCID: https://orcid.org/0000-0002-2694-2325)
- Stefan Kasper‐Virchow
- Annette Dam Fialla (ORCID: https://orcid.org/0000-0003-0890-4728)
- Freya Droege (ORCID: https://orcid.org/0000-0001-8811-507X)
- Elisabetta Buscarini (ORCID: https://orcid.org/0000-0003-0863-0624)
- Josefien Hessels (ORCID: https://orcid.org/0000-0002-9001-9893)
- Guido Manfredi (ORCID: https://orcid.org/0000-0003-0468-2945)
- A Guilhem (ORCID: https://orcid.org/0000-0003-4085-8784)
- Robert Mandić (ORCID: https://orcid.org/0000-0003-2379-5515)
- Sören Möller (ORCID: https://orcid.org/0000-0003-0858-4269)
- Anne‐Emmanuelle Fargeton (ORCID: https://orcid.org/0000-0003-3085-9580)
- Sanne Boerman
- Anette Drøhse Kjeldsen (ORCID: https://orcid.org/0000-0003-0593-6302)
- Martijn C. Post (ORCID: https://orcid.org/0000-0001-7400-5996)
- Jens Kjeldsen
- Hans‐Jurgen Mager
- Pernille Darre Haahr (ORCID: https://orcid.org/0009-0009-2562-127X)
Institutions
- Philipps University of Marburg (DE)
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
- University Medical Center Utrecht (NL)
- Hospices Civils de Lyon (FR)
- St. Antonius Ziekenhuis (NL)
- Region of Southern Denmark (DK)
- Essen University Hospital (DE)
- Azienda Ospedaliera Ospedale Maggiore (IT)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-09-23
- DOI
- https://doi.org/10.1002/bcp.70273
- Citations
- 1
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- Deutsche Forschungsgemeinschaft
- ZonMw
- St. Antonius Ziekenhuis